<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Sohm Inc. — News on 6ix</title>
    <link>https://6ix.com/company/sohm-inc</link>
    <description>Latest news and press releases for Sohm Inc. on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Thu, 06 Nov 2025 14:30:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/sohm-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835bff278dffbe2df118484.webp</url>
      <title>Sohm Inc.</title>
      <link>https://6ix.com/company/sohm-inc</link>
    </image>
    <item>
      <title>SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-releases-white-paper-on-abbie-a-cas9-guided-integrase-enabling-stable-gene-integration-and-creation-of-skov3-gys1-cell-line-for-drug-discovery</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-releases-white-paper-on-abbie-a-cas9-guided-integrase-enabling-stable-gene-integration-and-creation-of-skov3-gys1-cell-line-for-drug-discovery</guid>
      <pubDate>Thu, 06 Nov 2025 14:30:00 GMT</pubDate>
      <description>SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery.</description>
    </item>
    <item>
      <title>SOHM Notes FDA&apos;s Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-notes-fdas-evolving-gene-editing-framework-in-context-of-ongoing-abbie-platform-development</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-notes-fdas-evolving-gene-editing-framework-in-context-of-ongoing-abbie-platform-development</guid>
      <pubDate>Tue, 04 Nov 2025 14:30:00 GMT</pubDate>
      <description>SOHM Notes FDA&apos;s Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development.</description>
    </item>
    <item>
      <title>SOHM, Inc. Announces Allowance of Another Divisional Patent in the Republic of South Korea</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-announces-allowance-of-another-divisional-patent-in-the-republic-of-south-korea</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-announces-allowance-of-another-divisional-patent-in-the-republic-of-south-korea</guid>
      <pubDate>Mon, 15 Sep 2025 13:30:00 GMT</pubDate>
      <description>SOHM, Inc. Announces Allowance of Another Divisional Patent in the Republic of South Korea.</description>
    </item>
    <item>
      <title>SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-moving-and-expanding-commercialization-capabilities-with-its-new-vista-ca-facility</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-moving-and-expanding-commercialization-capabilities-with-its-new-vista-ca-facility</guid>
      <pubDate>Tue, 02 Sep 2025 13:30:00 GMT</pubDate>
      <description>SOHM, Inc., Moving and Expanding Commercialization Capabilities with its New Vista, CA Facility.</description>
    </item>
    <item>
      <title>SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-achieves-breakthrough-with-abbie-gene-editing-platform-advancing-strategic-partnership-and-licensing-opportunities</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-achieves-breakthrough-with-abbie-gene-editing-platform-advancing-strategic-partnership-and-licensing-opportunities</guid>
      <pubDate>Tue, 26 Aug 2025 13:30:00 GMT</pubDate>
      <description>SOHM Achieves Breakthrough with ABBIE Gene Editing Platform, Advancing Strategic Partnership and Licensing Opportunities.</description>
    </item>
    <item>
      <title>SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-launches-new-user-friendly-website-to-enhance-customer-investor-experience-and-engagement</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-launches-new-user-friendly-website-to-enhance-customer-investor-experience-and-engagement</guid>
      <pubDate>Mon, 21 Jul 2025 13:30:00 GMT</pubDate>
      <description>SOHM, Inc. Launches New User-Friendly Website to Enhance Customer, Investor Experience and Engagement.</description>
    </item>
    <item>
      <title>SOHM, Inc. Appoints Ravi Kapoor as an Independent Director</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-appoints-ravi-kapoor-as-an-independent-director</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-appoints-ravi-kapoor-as-an-independent-director</guid>
      <pubDate>Mon, 30 Jun 2025 13:30:00 GMT</pubDate>
      <description>SOHM, Inc. Appoints Ravi Kapoor as an Independent Director.</description>
    </item>
    <item>
      <title>SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-sets-strategic-goals-to-enter-biotechnology-driven-cosmeceuticals-market</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-sets-strategic-goals-to-enter-biotechnology-driven-cosmeceuticals-market</guid>
      <pubDate>Tue, 24 Jun 2025 13:30:00 GMT</pubDate>
      <description>SOHM, Inc. Sets Strategic Goals to Enter Biotechnology-Driven Cosmeceuticals Market.</description>
    </item>
    <item>
      <title>SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-welcomes-dr-larissa-karnaoukhova-as-new-vice-president-of-operations</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-welcomes-dr-larissa-karnaoukhova-as-new-vice-president-of-operations</guid>
      <pubDate>Wed, 11 Jun 2025 13:30:00 GMT</pubDate>
      <description>SOHM Inc. Welcomes Dr. Larissa Karnaoukhova as New Vice President of Operations.</description>
    </item>
    <item>
      <title>SOHM Inc. Welcomes Dr. Lucia Piccotti to Offer Expert Guidance on Cosmeceutical and Personal Health Product Research and Development</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-welcomes-dr-lucia-piccotti-to-offer-expert-guidance-on-cosmeceutical-and-personal-health-product-research-and-development</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-welcomes-dr-lucia-piccotti-to-offer-expert-guidance-on-cosmeceutical-and-personal-health-product-research-and-development</guid>
      <pubDate>Wed, 04 Jun 2025 13:30:00 GMT</pubDate>
      <description>SOHM Inc. Welcomes Dr. Lucia Piccotti to Offer Expert Guidance on Cosmeceutical and Personal Health Product Research and Development.</description>
    </item>
    <item>
      <title>SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-unveils-genetically-engineered-ovarian-cancer-cell-line-using-abbietm-platform-to-accelerate-gys1-drug-discovery</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-unveils-genetically-engineered-ovarian-cancer-cell-line-using-abbietm-platform-to-accelerate-gys1-drug-discovery</guid>
      <pubDate>Tue, 06 May 2025 14:15:00 GMT</pubDate>
      <description>SOHM, Inc., Unveils Genetically Engineered Ovarian Cancer Cell Line Using ABBIE(TM) Platform to Accelerate GYS1 Drug Discovery.</description>
    </item>
    <item>
      <title>Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization</title>
      <link>https://6ix.com/company/sohm-inc/news/dr-leonardo-mirandola-joins-sohm-inc-as-an-advisory-board-to-advance-car-t-cell-projects-toward-clinical-trials-and-commercialization</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/dr-leonardo-mirandola-joins-sohm-inc-as-an-advisory-board-to-advance-car-t-cell-projects-toward-clinical-trials-and-commercialization</guid>
      <pubDate>Fri, 02 May 2025 14:30:00 GMT</pubDate>
      <description>Dr. Leonardo Mirandola Joins SOHM, Inc. as an Advisory Board to Advance CAR-T Cell Projects Toward Clinical Trials and Commercialization.</description>
    </item>
    <item>
      <title>SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-awarded-european-patent-for-innovative-abbie-genome-editing-technology</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-awarded-european-patent-for-innovative-abbie-genome-editing-technology</guid>
      <pubDate>Thu, 01 May 2025 13:30:00 GMT</pubDate>
      <description>SOHM Inc. Awarded European Patent for Innovative ABBIE Genome Editing Technology.</description>
    </item>
    <item>
      <title>SOHM, Inc. Agrees to Licensing for Investigational and Pre-Clinical Studies for Groundbreaking ABBIE Genome Editing Technology for CAR-T Cell Cancer Therapies</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-agrees-to-licensing-for-investigational-and-pre-clinical-studies-for-groundbreaking-abbie-genome-editing-technology-for-car-t-cell-cancer-therapies</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-agrees-to-licensing-for-investigational-and-pre-clinical-studies-for-groundbreaking-abbie-genome-editing-technology-for-car-t-cell-cancer-therapies</guid>
      <pubDate>Mon, 28 Apr 2025 13:30:00 GMT</pubDate>
      <description>SOHM, Inc. Agrees to Licensing for Investigational and Pre-Clinical Studies for Groundbreaking ABBIE Genome Editing Technology for CAR-T Cell Cancer Therapies.</description>
    </item>
    <item>
      <title>SOHM, Inc.  Announces Patent Allowance/Approval in South Korea</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-announces-patent-allowanceapproval-in-south-korea</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-announces-patent-allowanceapproval-in-south-korea</guid>
      <pubDate>Wed, 16 Apr 2025 13:35:58 GMT</pubDate>
      <description>SOHM, Inc.  Announces Patent Allowance/Approval in South Korea.</description>
    </item>
    <item>
      <title>SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-shares-an-exciting-expansion-and-upcoming-presentation-on-abbie</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-shares-an-exciting-expansion-and-upcoming-presentation-on-abbie</guid>
      <pubDate>Thu, 10 Apr 2025 13:32:55 GMT</pubDate>
      <description>SOHM, Inc. Shares an Exciting Expansion and Upcoming Presentation on ABBIE.</description>
    </item>
    <item>
      <title>SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-launches-new-ai-team-to-advance-abbie-system-and-genome-editing-innovations</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-launches-new-ai-team-to-advance-abbie-system-and-genome-editing-innovations</guid>
      <pubDate>Mon, 07 Apr 2025 13:32:17 GMT</pubDate>
      <description>SOHM, Inc. Launches New AI Team to Advance ABBIE System and Genome Editing Innovations.</description>
    </item>
    <item>
      <title>SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-shares-groundbreaking-findings-in-abbie-technology</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-shares-groundbreaking-findings-in-abbie-technology</guid>
      <pubDate>Mon, 10 Mar 2025 13:33:15 GMT</pubDate>
      <description>SOHM, Inc. Shares Groundbreaking Findings in ABBIE Technology.</description>
    </item>
    <item>
      <title>SOHM, Inc. Announce Dr. Wei Zhu Onboard as Senior Marketing and Sales Consultant</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-announce-dr-wei-zhu-onboard-as-senior-marketing-and-sales-consultant</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-announce-dr-wei-zhu-onboard-as-senior-marketing-and-sales-consultant</guid>
      <pubDate>Wed, 20 Nov 2024 14:31:52 GMT</pubDate>
      <description>SOHM, Inc. Announce Dr. Wei Zhu Onboard as Senior Marketing and Sales Consultant.</description>
    </item>
    <item>
      <title>SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan&apos;s Patent Office (特許庁, Tokkyochō, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes</title>
      <link>https://6ix.com/company/sohm-inc/news/sohm-inc-announces-allowances-of-japanese-patent-claims-received-from-japans-patent-office-tokkyocho-jpo-protecting-transformative-sohm-abbie-genome-edited-sage-recombinant-organisms-cells-secretomes-exosomes</link>
      <guid isPermaLink="true">https://6ix.com/company/sohm-inc/news/sohm-inc-announces-allowances-of-japanese-patent-claims-received-from-japans-patent-office-tokkyocho-jpo-protecting-transformative-sohm-abbie-genome-edited-sage-recombinant-organisms-cells-secretomes-exosomes</guid>
      <pubDate>Thu, 14 Nov 2024 14:32:21 GMT</pubDate>
      <description>SOHM, Inc. Announces Allowances Of Japanese Patent Claims Received from Japan&apos;s Patent Office (特許庁, Tokkyochō, JPO) Protecting Transformative SOHM-ABBIE Genome Edited, SAGE Recombinant-Organisms, -Cells, -Secretomes, -Exosomes.</description>
    </item>
  </channel>
</rss>